Effects of oestrogen on vulvovaginal candidosis

As a frequently occurring infectious disease mainly caused by Candida albicans, vulvovaginal candidosis (VVC) affects more than 100 million women worldwide every year. Multiple factors that influence C. albicans colonisation have been linked to the incidence of VVC, including high levels of circulating oestrogen due to pregnancy, the use of oral contraceptives, and hormone replacement therapy. This review provides an overview of the current understanding of the mechanism(s) by which oestrogen contributes to VVC, which might provide meaningful guidance to the prevention and treatment of this disease.

Automated summary

Vulvovaginal candidosis (VVC) is a frequently occurring infectious disease caused mainly by Candida albicans, affecting over 100 million women worldwide annually. High levels of circulating oestrogen due to pregnancy, the use of oral contraceptives, and hormone replacement therapy are factors influencing C. albicans colonisation and the incidence of VVC.